In local recurrent CRPC specimens and CRPC metastases, the frequency of AURKA positivity was significantly higher compared to hormone naïve prostate cancer samples (P < 0.0001 and P < 0.0001, respectively, Table 1, Fig. 4d). The gene discussed is AURKA; the disease is Familial prostate cancer.